Top Markets
#1 Cortex Cortex +32.78%
#2 龙虾 (Lobster) 龙虾 (Lobster) +28.15%
#3 DexNet DexNet +23.20%
#4 Akedo Akedo +23.10%
#5 wojak wojak +17.64%
#6 Pons Pons +16.45%
#7 OpenEden OpenEden +12.59%
#8 Official Trump Official Trump +10.20%
#9 EXOD EXOD +9.04%
#10 Peapods Finance Peapods Finance +8.29%
Coin of the day
Cortex Cortex
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
Classement en actions #7141
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
Prix de l'action
$40.39
Dernière synchronisation: 2023-08-18
Capitalisation boursière
$1.70B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Chinook Therapeutics, Inc. (KDNY)

Catégorie

Healthcare
Historique du prix de l'action pour Chinook Therapeutics, Inc. (KDNY)
Prix de clôture le plus élevé : $40.34 le 2023-08-01

Prix de clôture le plus bas : $177.63 le 2015-04-01
Historique du prix de l'action de Chinook Therapeutics, Inc. de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 63.66%
2022 55.54%
2021 0.37%
2020 175.05%
2019 -57.15%
2018 -67.16%
2017 -26.51%
2016 -62.61%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.14 -12.77%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.74%
CH